TY  - GEN
AU  - Berg,David D
AU  - Wiviott,Stephen D
AU  - Scirica,Benjamin M
AU  - Gurmu,Yared
AU  - Mosenzon,Ofri
AU  - Murphy,Sabina A
AU  - Bhatt,Deepak L
AU  - Leiter,Lawrence A
AU  - McGuire,Darren K
AU  - Wilding,John P H
AU  - Johanson,Per
AU  - Johansson,Peter A
AU  - Langkilde,Anna Maria
AU  - Raz,Itamar
AU  - Braunwald,Eugene
AU  - Sabatine,Marc S
TI  - Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus
SN  - 1524-4539
PY  - 2020///0622
KW  - Adamantane
KW  - analogs & derivatives
KW  - Aged
KW  - Benzhydryl Compounds
KW  - adverse effects
KW  - Clinical Decision-Making
KW  - Decision Support Techniques
KW  - Diabetes Mellitus, Type 2
KW  - complications
KW  - Diabetic Cardiomyopathies
KW  - diagnosis
KW  - Dipeptides
KW  - therapeutic use
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - Female
KW  - Glucosides
KW  - Health Status
KW  - Heart Failure
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Patient Selection
KW  - Predictive Value of Tests
KW  - Randomized Controlled Trials as Topic
KW  - Reproducibility of Results
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sodium-Glucose Transporter 2 Inhibitors
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
UR  - https://doi.org/10.1161/CIRCULATIONAHA.119.042685
ER  -